Research Topics
| A R ShahaSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all?Phillip K Pellitteri
Department of Otolaryngology Head and Neck Surgery, Geisinger Medical Center, Danville, Pennsylvania, USA
Head Neck 28:166-75. 2006..Correlation of imaging results and pathologic node status will be important in determining the accuracy and, therefore, the value of this imaging modality for predicting the presence or absence of residual disease...
Recurrent differentiated thyroid cancerAshok R Shaha
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Endocr Pract 18:600-3. 2012..To discuss the risk of recurrence in patients with differentiated thyroid cancer and emphasize the importance of risk-group stratification...
Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposureBhuvanesh Singh
Laboratory of Epithelial Cancer Biology, Biology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, USA
BMC Genet 3:22. 2002..We used comparative genomic hybridization (CGH) to screen for the genetic aberrations in 71 patients with head and neck squamous cell carcinoma and stratified the findings by the status of tobacco/alcohol exposure...
Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysisCherry L Estilo
Dental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, USA
BMC Cancer 9:11. 2009..The present study is aimed at identifying potential candidate genes as prognostic markers in human oral tongue squamous cell carcinoma (SCC) by large scale gene expression profiling...
Complications of neck dissection for thyroid cancerAshok R Shaha
Ann Surg Oncol 15:397-9. 2008
Treatment of thyroid cancer based on risk groupsAshok Shaha
Memorial Sloan Kettering Cancer Center, Head and Neck Service, 1275 York Avenue, New York, NY 10021, USA
J Surg Oncol 94:683-91. 2006..The histopathologic studies are very important to distinguish well differentiated from the tall cell, insular, and poorly differentiated thyroid cancer...
Revision thyroid surgery - technical considerationsAshok R Shaha
Memorial Sloan Kettering Cancer Center, Cornell University Medical College, New York, NY 10065, USA
Otolaryngol Clin North Am 41:1169-83, x. 2008..Despite good surgical resection, the incidence of local recurrence in the central compartment is high in patients undergoing reoperative thyroid surgery...
Controversies in the management of thyroid noduleA R Shaha
Department of Surgery, Cornell University Medical College and Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Laryngoscope 110:183-93. 2000..This has generated considerable debate and panel discussions, and this article reviews this on-going debate...
Selective surgical management of well-differentiated thyroid cancerAshok Shaha
Attending Surgeon, Memorial Sloan Kettering Cancer Center, Head and Neck Service, New York, New York, USA
Ann N Y Acad Sci 1138:58-64. 2008..These patients do not respond well to RAI and are best followed with a PET scan. Overall survival in patients with well-differentiated thyroid cancer exceeds 95%...
Routine laryngoscopy in thyroid surgery: A valuable adjunctAshok R Shaha
Cornell University Medical Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Surgery 142:865-6. 2007
Minimally invasive parathyroidectomy: the role of radio-guided surgeryAshok R Shaha
Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Laryngoscope 112:2166-9. 2002..Objectives were to review our current experience with radio-guided parathyroid surgery and to compare various techniques of minimally invasive parathyroidectomy...
Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family membersAshok R Shaha
Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Laryngoscope 116:1704-7. 2006..However, its indications in adults remain unclear at this time...
Training in head and neck surgery and oncologyAshok R Shaha
Cornell University Medical College, New York, New York 10065, USA
J Surg Oncol 97:717-20. 2008..The head and neck surgeon (leader of the orchestra) must be familiar with appropriate indications of each treatment modality and outcome. The head and neck surgeon of today should be an all-rounder...
Parathyroid re-explorationAshok R Shaha
Head and Neck Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Otolaryngol Clin North Am 37:833-43, x. 2004..This article discusses the issues the parathyroid surgeon must consider before and during re-operative surgery,with special attention to recently introduced adjunctive techniques...
Airway management in anaplastic thyroid carcinomaAshok R Shaha
Head and Neck Surgery, Cornell University Medical Center, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Laryngoscope 118:1195-8. 2008..In patients who present with advanced anaplastic thyroid cancer, airway management is difficult because of bilateral vocal cord paralysis or tracheal invasion by the tumor. Airway management can be extremely complex in these patients...
Distant metastases from thyroid and parathyroid cancerA R Shaha
Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
ORL J Otorhinolaryngol Relat Spec 63:243-9. 2001..Patients with distant metastasis have recurrent progressive hypercalcemia along with high parathormone level...
Localization studies for hyperparathyroidism: implications for surgeryA R Shaha
Cornell University Medical College, Memorial Sloan Kettering Cancer Center, New York, USA
Acta Otorhinolaryngol Belg 55:139-45. 2001..The paper discusses the usefulness of these techniques in the initial exploration and in the re-exploration of primary and secondary hyperparathyroidism...
Implications of prognostic factors and risk groups in the management of differentiated thyroid cancerAshok R Shaha
Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Laryngoscope 114:393-402. 2004..The study describes the author's treatment approach related to the extent of thyroidectomy and adjuvant therapy based on various risk groups and the long-term survival...
Genome-wide screening for radiation response factors in head and neck cancerB Singh
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Laryngoscope 110:1251-6. 2000....
Role of fine-needle aspiration biopsy and frozen section analysis in the surgical management of thyroid tumorsA D Brooks
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Ann Surg Oncol 8:92-100. 2001..Intraoperative FS added very little to surgical management. The majority of thyroid operations at this institution are planned and performed based on known prognostic factors and intraoperative findings...
Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinomaS L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 19:1105-10. 2001..To evaluate the feasibility and efficacy of concomitant boost radiotherapy (RT) plus cisplatin-based chemotherapy compared with standard fractionation RT for patients with advanced nasopharyngeal cancer...
Management of thyroid nodules and surgery for differentiated thyroid cancerN G Iyer
Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York 10065, USA
Clin Oncol (R Coll Radiol) 22:405-12. 2010..The onus is on the physician to avoid treatment-related complications from thyroid surgery and to offer the most efficient and cost-effective therapeutic option...
Anatomy of thyroid and parathyroid glands and neurovascular relationsA Mohebati
Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Clin Anat 25:19-31. 2012..This information should aid the surgeon in appropriate identification and preservation of the function of these structures and to avoid the pitfalls of the operation...
Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplificationB Singh
Laboratory of Epithelial Cancer Biology, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cancer Res 61:4506-13. 2001..The use of these yeast artificial chromosome clones as a probe for fluorescence in situ hybridization analysis allowed a detailed characterization and quantification of the 3q amplification and refinement of unassigned SKY breakpoints...
Complications of thyroid surgery: prevention and managementN Gopalakrishna Iyer
Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Minerva Chir 65:71-82. 2010..This review addresses the common complications that occur during thyroid surgery and the issues therein...
Hürthle cell carcinoma: a critical histopathologic appraisalA Stojadinovic
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 19:2616-25. 2001..Unlike differentiated thyroid cancer, nodal metastases predict a worse outcome in widely invasive Hürthle cell carcinoma, as does extrathyroidal extension...
Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancerYungpo Bernard Su
Department of a Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer J 12:182-8. 2006..To evaluate the ability of granulocyte-stimulating factor to decrease mucositis during postoperative radiotherapy for stage II-IV squamous head and neck cancer in a randomized, double-blind, placebo-controlled trial...
Poorly differentiated and anaplastic thyroid cancerKepal N Patel
Department of Surgery, Stony Brook University Hospital, Stony Brook, New York, USA
Cancer Control 13:119-28. 2006..CONCLUSIONS: PDTC and ATC are rare diseases that carry a poor prognosis. Recognition of their different clinicopathologic features is important to the optimal management of these tumors...
Invited commentary: Vocal cord evaluation in thyroid surgeryAshok R Shaha
Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Surgery 139:363-4. 2006
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigmDavid G Pfister
Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 24:1072-8. 2006..Cetuximab has activity in squamous cell carcinoma and enhances both chemotherapy and radiotherapy. We conducted a pilot phase II study of a new combined-modality paradigm of targeted therapy (cetuximab) with chemoradiotherapy...
Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approachesChandrakanth Are
Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, 1233 York Avenue, 16 I, New York, New York 10021, USA
Ann Surg Oncol 13:453-64. 2006..We also reviewed the individual and combined roles of surgery, radiotherapy, chemotherapy, and newer therapeutic options in the management of ATC...
Do pathologic and molecular analyses of neck dissection specimens justify the preservation of level IV for laryngeal squamous carcinoma with clinically negative neck?Mohamed N Elsheikh
Department of Otolaryngology Head and Neck Surgery, Tanta University, Tanta, Egypt
J Am Coll Surg 202:320-3. 2006
Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynxIan Ganly
Department of Head and Neck Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Arch Otolaryngol Head Neck Surg 132:59-66. 2006..These patients have poorer survival outcomes manifested by local, regional, and distant disease progression...
Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynxKaren Lin
Head and Neck Service, Department of Surgery, P. O. Box 285, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York 10021, USA
Head Neck 27:1042-8. 2005..CONCLUSIONS: The rates of SPMADT after treatment of SCCOC and SCCL are comparable, but the patterns are different. Smoking and alcohol use are independent predictors of SPMADT development...
TNM classification of thyroid carcinomaAshok R Shaha
Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, 10021, USA
World J Surg 31:879-87. 2007..The TNM staging system helps reporting our data and comparing results in different parts of the world. However, there is no level I evidence in thyroid cancer...
Medical management of thyroid cancer: a risk adapted approachR Michael Tuttle
Joan and Sanford I Weill Medical College of Cornell University, New York, New York 10021, USA
J Surg Oncol 97:712-6. 2008....
Hürthle cell carcinoma: a 60-year experienceAlexander Stojadinovic
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Ann Surg Oncol 9:197-203. 2002..Recurrence portends a poor outcome. High-risk patients and those with recurrence should be considered for adjuvant therapy...
Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancerRamesh Rengan
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Am J Clin Oncol 31:465-9. 2008..To examine the long-term neck failure outcome in patients with advanced head and neck cancer treated on larynx/organ preservation protocols at Memorial Sloan-Kettering Cancer Center...
Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomasChandrakanth Are
Division of Surgical Oncology, Department of Surgery, Eppley Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA
Ann Surg Oncol 14:3210-5. 2007..The aim of our study was to determine if these FDG-PET-detected thyroid malignancies represent a more-aggressive variant of primary thyroid carcinoma...
Routine drainage after thyroid surgery--a meta-analysisAlvaro Sanabria
Department of Surgery, Universidad de La Sabana, Bogota, Colombia
J Surg Oncol 96:273-80. 2007..In addition, the mean length of hospital stay was longer in the routine drainage group...
Identification of angiogenesis/metastases genes predicting chemoradiotherapy response in patients with laryngopharyngeal carcinomaIan Ganly
Laboratory of Epithelial Cancer Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 25:1369-76. 2007..To identify genes related to angiogenesis/metastasis that predict locoregional failure in patients with laryngopharyngeal cancer (LPC) undergoing chemoradiotherapy (CRT) treatment...
Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levelsSeng C Ong
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Nucl Med 48:501-7. 2007..The role of (18)F-FDG PET in MTC remains somewhat unclear. We reviewed our own experience with (18)F-FDG PET in postthyroidectomy MTC patients with elevated calcitonin...
Neck dissection for laryngeal cancerAlfio Ferlito
Department of Surgical Sciences, ENT Clinic, University of Udine, Udine, Italy
J Am Coll Surg 207:587-93. 2008
Papillary microcarcinoma of the thyroidAshok R Shaha
J Surg Oncol 95:532-3. 2007
FDG-PET detected thyroid incidentalomas: need for further investigation?Chandrakanth Are
Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, 1233 York Avenue, 16 I, New York, New York, 10021, USA
Ann Surg Oncol 14:239-47. 2007..Incidental thyroid abnormalities are increasingly detected in patients undergoing PET scans. The aim of this study was to review our experience with the management of PET detected thyroid incidentalomas in a large single institution series...
New molecular diagnostic methods in head and neck cancerJuan Pablo Rodrigo
Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain
Head Neck 27:995-1003. 2005..However, despite the great promise of these new molecular approaches for cancer detection, much of the current technology limits their implementation into routine clinical use...
Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodesAlfio Ferlito
Department of Otolaryngology Head and Neck Surgery, University of Udine, Policlinico Universitario, Piazzale S Maria della Misericordia, 1 33100 Udine, Italy
Oral Oncol 38:747-51. 2002....
Current management of cutaneous malignant melanoma of the head and neckJesus E Medina
Department of Otolaryngology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
Acta Otolaryngol 122:900-6. 2002
Is the standard radical neck dissection no longer standard?Alfio Ferlito
Acta Otolaryngol 122:792-5. 2002
"Skip metastases" from head and neck cancersAlfio Ferlito
Acta Otolaryngol 122:788-91. 2002
Prospective functional voice assessment in patients undergoing thyroid surgeryAlexander Stojadinovic
Department of Surgery, Walter Reed Army Medical Center, Washington, D.C, USA
Ann Surg 236:823-32. 2002..Factors other than laryngeal nerve injury appear to alter post-thyroidectomy voice. The variability of patient symptoms underscores the importance of understanding the physiology of dysphonia...
Genome-wide appraisal of thyroid cancer progressionVolkert B Wreesmann
Laboratory of Epithelial Cancer Biology, Head and Neck Service, New York, New York 10021, USA
Am J Pathol 161:1549-56. 2002..Our data suggests that the development of chromosomal instability underlies the progression to more aggressive phenotypes of thyroid cancer and sheds light on the possible genomic aberrations that may be selected for during this process...
Recurrent differentiated thyroid carcinoma: biological implications of age, method of detection, and site and extent of recurrenceAlexander Stojadinovic
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Ann Surg Oncol 9:789-98. 2002..We identified factors predictive of outcome for recurrent differentiated thyroid carcinoma (DTC)...
Improved outcomes in patients with osteogenic sarcoma of the head and neckSnehal G Patel
Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer 95:1495-503. 2002..The results of the current study represent a considerable improvement over the authors' previously published experience and compare favorably with the results reported in the literature...
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomasBhuvanesh Singh
Laboratory of Epithelial Cancer Biology, The Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Am J Pathol 161:365-71. 2002..6; 95% confidence interval = 1.9 to 29.6). The findings suggest that the 3q copy number status is an important marker for tumor progression and prognostication in patients with head and neck squamous cell carcinoma...
Status of carotid resection in head and neck cancerJavier Gavilan
Department of Otorhinolaryngology, La Paz Hospital, Autonomous University, Madrid, Spain
Acta Otolaryngol 122:453-5. 2002
Is elective neck treatment indicated in patients with squamous cell carcinoma of the maxillary sinus?Alessandra Rinaldo
Department of Otolaryngology Head and Neck Surgery, University of Udine, Policlinico Universitario, Italy
Acta Otolaryngol 122:443-7. 2002
The role of operations for distantly metastatic well-differentiated thyroid carcinomaAlexander Stojadinovic
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Surgery 131:636-43. 2002..Complete metastasectomy may be associated with improved survival for localized distant disease. Palliative resection is indicated to improve quality of life for symptomatic distant metastasis...
Prediction of survival in patients with head and neck cancer using the histoculture drug response assayBhuvanesh Singh
Head and Neck and Medical Oncology Services, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
Head Neck 24:437-42. 2002..In this study, we have correlated the HDRA assessment with survival in patients with head and neck squamous cell carcinoma (HNSCC)...
Primary mucosal malignant melanoma of the head and neckSnehal G Patel
Head and Neck Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
Head Neck 24:247-57. 2002..This study aims to assess the outcome and identify clinical and histologic prognostic indicators in a recent cohort of patients with MMHN treated at a single institution...
Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysisAlexander Stojadinovic
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Hum Pathol 34:54-64. 2003..The molecular phenotype, p27(+)Bcl-2(+)Ki-67(-)mdm2(+), appears to be unique to nonmalignant parathyroid tumors, and multimarker phenotypes are more complex in carcinomas...
Current management of tonsillar cancerEric M Genden
Department of Otolaryngology-Head and Neck Surgery, Mount Sinai School of Medicine, New York, New York, USA
Oral Oncol 39:337-42. 2003..While advanced lesions are often treated with a combination of radiation, chemotherapy, and surgical ablation, management of the neck and distant metastases continues to present a therapeutic dilemma...
Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancerBenjamin D Rosenbluth
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 63:1419-26. 2005..Ideal planning target volume doses have yet to be determined. Additional patients and long-term follow-up are needed to confirm these preliminary findings and to clarify late toxicities...
Is total thyroidectomy the best possible surgical management for well-differentiated thyroid cancer?Robert Udelsman
Yale University School of Medicine, PO Box 208062, New Haven, CT 06520 8062, USA
Lancet Oncol 6:529-31. 2005
Elective and therapeutic selective neck dissectionAlfio Ferlito
Department of Surgical Sciences, ENT Clinic, University of Udine, Policlinico Universitario, Piazzale S Maria della Misericordia, 33100 Udine, Italy
Oral Oncol 42:14-25. 2006....
Locally advanced thyroid cancerKepal N Patel
Head and Neck Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Curr Opin Otolaryngol Head Neck Surg 13:112-6. 2005..The understanding and recognition of histopathological variations, such as poorly differentiated thyroid cancer is also important. New molecular markers are needed to help identify and predict aggressive tumor behavior...
Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neckVolkert B Wreesmann
Laboratory of Epithelial Cancer Biology, Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 22:3965-72. 2004..A sequential approach to control for multiple comparisons and effect of confounding variables allows the identification of clinically relevant aberrations. The significance of each individual abnormality merits further consideration...
Medullary thyroid carcinomaErik G Cohen
Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Acta Otolaryngol 124:544-57. 2004
Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entityVolkert B Wreesmann
Laboratory of Epithelial Cancer Biology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Genes Chromosomes Cancer 40:355-64. 2004..Our findings suggest a stronger relationship between the FVPTC and FTA/FTC than previously appreciated and support further consideration of the current classification of thyroid neoplasms...
Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic markerVolkert B Wreesmann
Laboratory of Epithelial Cancer Biology, Head and Neck Service, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer Res 64:3780-9. 2004..3; 95% confidence interval, 1.1-5.5; P = 0.03). Our data suggest that MUC1 dysregulation is associated with aggressive behavior of PTC and may serve as a prognostic marker and potential therapeutic target in this disease...
Parapharyngeal lymph node metastasis: an unusual presentation of papillary thyroid carcinomaDavide Lombardi
Department of Otorhinolaryngology, University of Brescia, Piazza Spedali Civili, 1, 25123, Brescia, Italy
Head Neck 26:190-6. 2004..The occurrence of a metastasis in such unusual site, even though rarely reported, does not seem to significantly affect the prognosis of the disease...
Prognostic factors in papillary thyroid carcinoma and implications of large nodal metastasisAshok R Shaha
Surgery 135:237-9. 2004
Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynxJeannette Marie S Matsuo
Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Ann Surg 238:412-21; discussion 421-2. 2003..CONCLUSION: Regardless of the index treatment modality, primary tumor site, or T stage, a higher clinical N stage at the time of presentation independently and significantly increases the risk of DM in patients with SCCL...
Current management of mucosal melanoma of the head and neckJesus E Medina
Department of Otolaryngology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
J Surg Oncol 83:116-22. 2003..A better grasp of the best means of treating MuM will likely come only when large referral centers are able to pool their experiences with these uncommon yet virulent malignancies...
Changing concepts in the surgical management of the cervical node metastasisAlfio Ferlito
Department of Otolaryngology-Head and Neck Surgery, University of Udine, Policlinico Universitario, Piazzale S. Maria della Misericordia, I-33100, Udine, Italy
Oral Oncol 39:429-35. 2003
Sentinel lymph node biopsy in head and neck cancerKaren T Pitman
Department of Otolaryngology, University of Mississippi Medical Center, Jackson, MS, USA
Oral Oncol 39:343-9. 2003..As a consequence, the application of SLNB to head and neck cancers remains an experimental technique--one which has not yet acquired the status of the standard of patient care...
Management of well-differentiated thyroid carcinoma presenting within a thyroglossal duct cystSnehal G Patel
Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
J Surg Oncol 79:134-9; discussion 140-1. 2002..Results of adequate excision using the Sistrunk operation are excellent and the concept of risk-groups should be used to identify patients, who would benefit from more aggressive treatment...
